Annual report pursuant to Section 13 and 15(d)
Nature of Business (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||||
Write off of COVID-19 PCR testing inventory and equipment | $ 6,100 | $ 0 | $ 6,061 | $ 0 |
Write off of remaining COVID-19 PCR testing inventory | 5,300 | |||
PCR testing equipment, general and administrative | 800 | |||
Grant income recognized, COVID-19 | 0 | 0 | 7,900 | |
Accrued deferred social security taxes, COVID-19 | 3,000 | |||
Amount of ERTC recognized, COVID-19 | $ 0 | $ 4,400 | $ 1,900 |
X | ||||||||||
- Definition Employee Retention Tax Credit, CARES Act No definition available.
|
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, Exit Costs, COVID-19 No definition available.
|
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, General and Administrative Expenses, COVID-19 No definition available.
|
X | ||||||||||
- Definition Polymerase Chain Reaction Testing, Write-Offs, COVID-19 No definition available.
|
X | ||||||||||
- Definition Proceeds from Government Assistance, CARES Act No definition available.
|
X | ||||||||||
- Definition Social Security Tax, Employer, Deferral, CARES Act No definition available.
|
X | ||||||||||
- References No definition available.
|